This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Shuichi Sakuda: Innovator in Pharmaceutical Chemistry
Introduction
Shuichi Sakuda is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Sakuda holds a patent for 4,4-difluoro-2,3,4,5-tetrahydro-1H-1-benzoazepine derivatives and drug compositions containing them. This patent includes compounds or salts thereof and pharmaceutical compositions that utilize these compounds along with a pharmaceutically acceptable carrier. The unique chemical structure of these compounds features a difluoro group on a ring carbon atom adjacent to an azepine ring carbon atom that is substituted with a methylidene group. These pharmaceutical compositions are particularly useful as oxytocin antagonists and are effective in inhibiting threatened premature birth or abortion, as well as precesarean birth. They also serve as remedies for dysmenorrhea and other related conditions.
Career Highlights
Sakuda is associated with Yamanouchi Pharmaceutical Company Ltd., where he has been instrumental in advancing research and development in pharmaceutical products. His work has led to innovative solutions that address critical health issues.
Collaborations
Throughout his career, Sakuda has collaborated with esteemed colleagues such as Akira Matsuhisa and Takeshi Murakami. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Shuichi Sakuda's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key figure in the industry. His work continues to impact the field positively, providing valuable solutions for various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile